产品: | Paxillin 抗体 |
货号: | AF6835 |
描述: | Rabbit polyclonal antibody to Paxillin |
应用: | ELISA(peptide) |
反应: | Human, Mouse, Rat |
分子量: | 65kD(Calculated). |
蛋白号: | P49023 |
RRID: | AB_2847558 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF6835, RRID:AB_2847558.
展开/折叠
FLJ16691; FLJ23042; Paired box protein Pax 1; PAX 1; PAX1; PAXI_HUMAN; Paxillin alpha; Paxillin; PXN; PXN protein;
抗原和靶标
A synthesized peptide derived from human Paxillin.
- P49023 PAXI_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDDLDALLADLESTTSHISKRPVFLSEETPYSYPTGNHTYQEIAVPPPVPPPPSSEALNGTILDPLDQWQPSSSRFIHQQPQSSSPVYGSSAKTSSVSNPQDSVGSPCSRVGEEEHVYSFPNKQKSAEPSPTVMSTSLGSNLSELDRLLLELNAVQHNPPGFPADEANSSPPLPGALSPLYGVPETNSPLGGKAGPLTKEKPKRNGGRGLEDVRPSVESLLDELESSVPSPVPAITVNQGEMSSPQRVTSTQQQTRISASSATRELDELMASLSDFKIQGLEQRADGERCWAAGWPRDGGRSSPGGQDEGGFMAQGKTGSSSPPGGPPKPGSQLDSMLGSLQSDLNKLGVATVAKGVCGACKKPIAGQVVTAMGKTWHPEHFVCTHCQEEIGSRNFFERDGQPYCEKDYHNLFSPRCYYCNGPILDKVVTALDRTWHPEHFFCAQCGAFFGPEGFHEKDGKAYCRKDYFDMFAPKCGGCARAILENYISALNTLWHPECFVCRECFTPFVNGSFFEHDGQPYCEVHYHERRGSLCSGCQKPITGRCITAMAKKFHPEHFVCAFCLKQLNKGTFKEQNDKPYCQNCFLKLFC
翻译修饰 - P49023 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
T29 | Phosphorylation | Uniprot | |
Y31 | Phosphorylation | A0A059VC25 (FAK) , Q13882 (PTK6) , P00519 (ABL1) , Q05397 (PTK2) | Uniprot |
S32 | Phosphorylation | Uniprot | |
Y33 | Phosphorylation | Uniprot | |
T35 | Phosphorylation | Uniprot | |
T39 | Phosphorylation | Uniprot | |
Y40 | Phosphorylation | P12931 (SRC) | Uniprot |
S83 | Phosphorylation | Uniprot | |
S84 | Phosphorylation | Uniprot | |
S85 | Phosphorylation | Q16539 (MAPK14) , Q00535 (CDK5) | Uniprot |
Y88 | Phosphorylation | P12931 (SRC) | Uniprot |
S90 | Phosphorylation | Uniprot | |
S95 | Phosphorylation | Uniprot | |
S103 | Phosphorylation | Uniprot | |
S106 | Phosphorylation | Uniprot | |
C108 | S-Nitrosylation | Uniprot | |
S109 | Phosphorylation | Uniprot | |
Y118 | Phosphorylation | P00519 (ABL1) , Q05397 (PTK2) , Q13882 (PTK6) , A0A059VC25 (FAK) | Uniprot |
S119 | Phosphorylation | Uniprot | |
K123 | Ubiquitination | Uniprot | |
K125 | Ubiquitination | Uniprot | |
S126 | Phosphorylation | Q9UBE8 (NLK) | Uniprot |
S130 | Phosphorylation | P27361 (MAPK3) | Uniprot |
T132 | Phosphorylation | Uniprot | |
S135 | Phosphorylation | Uniprot | |
T136 | Phosphorylation | Uniprot | |
S137 | Phosphorylation | Uniprot | |
S140 | Phosphorylation | Uniprot | |
S143 | Phosphorylation | Uniprot | |
S178 | Phosphorylation | P45983 (MAPK8) | Uniprot |
Y181 | Phosphorylation | Uniprot | |
S188 | Phosphorylation | Uniprot | |
S219 | Phosphorylation | Uniprot | |
S230 | Phosphorylation | Uniprot | |
S243 | Phosphorylation | Uniprot | |
S244 | Phosphorylation | Uniprot | |
T249 | Phosphorylation | Uniprot | |
S250 | Phosphorylation | Uniprot | |
T251 | Phosphorylation | Uniprot | |
T255 | Phosphorylation | Uniprot | |
S258 | Phosphorylation | Q13153 (PAK1) | Uniprot |
S260 | Phosphorylation | Uniprot | |
S261 | Phosphorylation | Uniprot | |
T263 | Phosphorylation | Uniprot | |
S272 | Phosphorylation | Q13177 (PAK2) , O96013 (PAK4) , Q13153 (PAK1) | Uniprot |
S274 | Phosphorylation | Q13177 (PAK2) | Uniprot |
K277 | Ubiquitination | Uniprot | |
S302 | Phosphorylation | Uniprot | |
S303 | Phosphorylation | Uniprot | |
T318 | Phosphorylation | Uniprot | |
S320 | Phosphorylation | Uniprot | |
S321 | Phosphorylation | Uniprot | |
S322 | Phosphorylation | Uniprot | |
S332 | Phosphorylation | Uniprot | |
S336 | Phosphorylation | Uniprot | |
S340 | Phosphorylation | Uniprot | |
K355 | Ubiquitination | Uniprot | |
T371 | Phosphorylation | Uniprot | |
Y409 | Phosphorylation | Uniprot | |
S414 | Phosphorylation | Uniprot | |
Y468 | Phosphorylation | Uniprot | |
S533 | Phosphorylation | Uniprot | |
K540 | Ubiquitination | Uniprot |
研究背景
Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).
Phosphorylated by MAPK1/ERK2 (By similarity). Phosphorylated on tyrosine residues during integrin-mediated cell adhesion, embryonic development, fibroblast transformation and following stimulation of cells by mitogens. Phosphorylation at Ser-244 by CDK5 reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Phosphorylation at Tyr-31 and Tyr-118 by PTK6 promote the activation of RAC1 via CRK/CrKII, thereby promoting migration and invasion. Phosphorylation at Ser-250 by SLK is required for PXN redistribution and cell motility.
Cytoplasm>Cytoskeleton. Cell junction>Focal adhesion. Cytoplasm>Cell cortex.
Note: Colocalizes with integrins at the cell periphery. Colocalize with PXN to membrane ruffles and the leading edge of migrating cells (PubMed:23128389).
Binds in vitro to vinculin as well as to the SH3 domain of SRC and, when tyrosine phosphorylated, to the SH2 domain of V-CRK. Isoform beta binds to PTK2/FAK1 but weakly to vinculin. Isoform gamma binds to vinculin but only weakly to PTK2/FAK1. Interacts with GIT1, NUDT16L1/SDOS and TGFB1I1. Component of cytoplasmic complexes, which also contain GIT1, ARHGEF6 and PAK1. Interacts with PTK2/FAK1 and PTK2B/PYK2. Binds ASAP2. Interacts with unphosphorylated ITGA4. Interacts with RNF5 and PDCD10. Interacts with NEK3 and this interaction is prolactin-dependent. Interacts with PTK6. Interacts with SORBS1, PARVA and PARVB. Interacts (via cytoplasmic domain) with CEACAM1; the interaction is phosphotyrosyl-dependent. Interacts with LIMA1; this complex stabilizes actin dynamics.
Belongs to the paxillin family.
研究领域
· Cellular Processes > Cellular community - eukaryotes > Focal adhesion. (View pathway)
· Cellular Processes > Cell motility > Regulation of actin cytoskeleton. (View pathway)
· Human Diseases > Infectious diseases: Bacterial > Bacterial invasion of epithelial cells.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
· Human Diseases > Cancers: Overview > Proteoglycans in cancer.
· Organismal Systems > Immune system > Chemokine signaling pathway. (View pathway)
· Organismal Systems > Immune system > Leukocyte transendothelial migration. (View pathway)
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.